Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueLiabilities and Shareholders EquityNon-Current AssetsNon-Current DebtNon-Current Deffered RevenueOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPreferred SharesPrepaid AssetsProperty, Plant & Equipment (Net)Retained EarningsShareholder's EquityShares OutstandingShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Viridian Therapeutics, Inc.\DE (VRDN) Current Leases (2016)

Viridian Therapeutics, Inc.\DE has reported Current Leases over the past 3 years, most recently at $4000.0 for Q4 2016.

  • Quarterly results put Current Leases at $4000.0 for Q4 2016, down 95.45% from a year ago — trailing twelve months through Dec 2016 was $4000.0 (down 95.45% YoY), and the annual figure for FY2016 was $4000.0, down 95.45%.
  • Current Leases for Q4 2016 was $4000.0 at Viridian Therapeutics, Inc.\DE, down from $88000.0 in the prior quarter.
  • Over the last five years, Current Leases for VRDN hit a ceiling of $88000.0 in Q4 2015 and a floor of $4000.0 in Q4 2016.
  • Median Current Leases over the past 3 years was $80000.0 (2014), compared with a mean of $57333.3.
  • Biggest five-year swings in Current Leases: increased 10.0% in 2015 and later tumbled 95.45% in 2016.
  • Viridian Therapeutics, Inc.\DE's Current Leases stood at $80000.0 in 2014, then increased by 10.0% to $88000.0 in 2015, then tumbled by 95.45% to $4000.0 in 2016.
  • The last three reported values for Current Leases were $4000.0 (Q4 2016), $88000.0 (Q4 2015), and $80000.0 (Q4 2014) per Business Quant data.